The importance of genetics in an advanced integrative model of autism spectrum disorder

Abstract

Genes have long been considered to cause autism spectrum disorder (ASD). However, data obtained over the last 10 years indicate that the true role of genetics in ASD and the cost-benefit ratio of genetic testing following an ASD diagnosis warrant further investigation. ASD is heterogeneous with high individual complexity, and new findings related to systemic alterations in ASD (in addition to genetics) should be considered when attempting to optimize patient health. However, for some people with ASD and their families, genetic testing can identify genetic mutations or chromosomic alterations. This review mainly considers recent research (the last 5 years) on the role of genetic factors in ASD and the importance of genetic testing in a new Advanced Integrative Model of ASD.

Keywords

Genetic testing / Advanced Integrative Model / mutation

References

[1] HoangN,SchererSW.Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders.NPJ Genom Med2018;3:27 PMCID:PMC6145925

[2] DiasCM.Recent advances in understanding the genetic architecture of autism.Annu Rev Genomics Hum Genet2020;21:289-304

[3] Hertz-PicciottoI,KrakowiakP.Understanding environmental contributions to autism: causal concepts and the state of science.Autism Res2018;11:554-86

[4] NieslerB.Emerging evidence for gene mutations driving both brain and gut dysfunction in autism spectrum disorder.Mol Psychiatry2021;26:1442-4 PMCID:PMC8159735

[5] Ghrálaigh F, McCarthy E, Murphy DN, Gallagher L, Lopez LM. Brief report: evaluating the diagnostic yield of commercial gene panels in autism.J Autism Dev Disord2022;

[6] ZuritaMF,SandovalME.Analysis of gut microbiome, nutrition and immune status in autism spectrum disorder: a case-control study in Ecuador.Gut Microbes2020;11:453-64 PMCID:PMC7524316

[7] MyersSM,BernierR.Insufficient evidence for “autism-specific” genes.Am J Hum Genet2020;106:587-95 PMCID:PMC7212289

[8] LisikMZ,SierońAL.Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in its pathogenesis?.Neurodegener Dis2015;15:45-9

[9] Marco BD, Bonaccorso CM, Aloisi E, D'Antoni S, Catania MV. Neuro-inflammatory mechanisms in developmental disorders associated with intellectual disability and autism spectrum disorder: a neuro- immune perspective.CNS Neurol Disord Drug Targets2016;15:448-63

[10] BarnhillK,MorenoHT.Brief report: implementation of a specific carbohydrate diet for a child with autism spectrum disorder and fragile X syndrome.J Autism Dev Disord2020;50:1800-8

[11] NolanSO,BinderMS.Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse.PLoS One2022;17:e0262916 PMCID:PMC8797197

[12] NapoliE,WangJY.Allopregnanolone treatment improves plasma metabolomic profile associated with gaba metabolism in fragile X-associated tremor/ataxia syndrome: a pilot study.Mol Neurobiol2019;56:3702-13 PMCID:PMC6401336

[13] SongG,WongS.Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine.Mol Med2016;22:548-59 PMCID:PMC5082295

[14] ValentiD,DeFilippis B,VaccaRA.Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, Autism, Fragile X and Rett syndrome.Neurosci Biobehav Rev2014;46 Pt 2:202-17

[15] MüllerM.Disturbed redox homeostasis and oxidative stress: potential players in the developmental regression in Rett syndrome.Neurosci Biobehav Rev2019;98:154-63

[16] CarlssonT,ButwickaA.Association of cumulative early medical factors with autism and autistic symptoms in a population-based twin sample.Transl Psychiatry2022;12:73 PMCID:PMC8863884

[17] TorresEB.Reframing psychiatry for precision medicine.J Pers Med2020;10:144 PMCID:PMC7711577

[18] VolkHE,ChenA.Considering toxic chemicals in the etiology of autism.Pediatrics2022;149:e2021053012

[19] BougeardC,SchmidR,BuitelaarJ.Prevalence of autism spectrum disorder and co-morbidities in children and adolescents: a systematic literature review.Front Psychiatry2021;12:744709 PMCID:PMC8579007

[20] LeaderG,CunninghamS.Gastrointestinal symptoms in autism spectrum disorder: a systematic review.Nutrients2022;14:1471

[21] IsakssonJ,AhoN,MarschikPB.Nonshared environmental factors in the aetiology of autism and other neurodevelopmental conditions: a monozygotic co-twin control study.Mol Autism2022;13:8 PMCID:PMC8858556

[22] WeiH,WangT,ZhangK.Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.J Neural Transm2021;128:717-34

[23] DavidMM,OzturkA.Comorbid analysis of genes associated with autism spectrum disorders reveals differential evolutionary constraints.PLoS One2016;11:e0157937

[24] Diaz-BeltranL,VarmaM.Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes.BMC Genomics2017;18:1-14

[25] KleinL,EapenV,LinPI.Exploring polygenic contributors to subgroups of comorbid conditions in autism spectrum disorder.Sci Rep2022;12:3416 PMCID:PMC8888546

[26] FerreiraML.Rationale of an advanced integrative approach applied to autism spectrum disorder: review, discussion and proposal.J Pers Med2021;11:514 PMCID:PMC8230111

[27] CawthorpeD.A 16-year cohort analysis of autism spectrum disorder-associated morbidity in a pediatric population.Front Psychiatry2018;9:635 PMCID:PMC6281889

[28] OzonoffS,HanzelEP.Onset patterns in autism: variation across informants, methods, and timing.Autism Res2018;11:788-97 PMCID:PMC5992045

[29] RoseS,RossignolDA,KahlerSG.Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder.Mol Diagn Ther2018;22:571-93 PMCID:PMC6132446

[30] GoncalvesMVM,BraatzV.Pediatric acute-onset neuropsychiatric syndrome (PANS) misdiagnosed as autism spectrum disorder.Immunol Lett2018;203:52-3

[31] ShulyakovaN,MillsLR.Mitochondrial dysfunction in the pathogenesis of rett syndrome: implications for mitochondria-targeted therapies.Front Cell Neurosci2017;11:58 PMCID:PMC5348512

[32] KreimanBL.State of the art of genetic testing for patients with autism: a practical guide for clinicians.Semin Pediatr Neurol2020;34:100804

[33] StaffordCF.Impact of genetic and genomic testing on the clinical management of patients with autism spectrum disorder.Genes2022;13:585 PMCID:PMC9030515

[34] RichardsC,GrovesL,OliverC.Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.Lancet Psychiatry2015;2:909-16

[35] ShimizuH,YamamotoN,OzawaH.Overlap between epilepsy and neurodevelopmental disorders: insights from clinical and genetic studies. In: Czuczwar SJ, editor. Epilepsy. Exon Publications; 2022. pp. 41-54.

[36] FryeRE,FatemiSH.Neuropathological mechanisms of seizures in autism spectrum disorder.Front Neurosci2016;10:192 PMCID:PMC4861974

[37] FryeRE.Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder.Epilepsy Behav2015;47:147-57

[38] KuoSS,FuJM.Developmental variability in autism across 17 000 autistic individuals and 4000 siblings without an autism diagnosis: comparisons by cohort, intellectual disability, genetic etiology, and age at diagnosis.JAMA Pediatr2022;176:915-23 PMCID:PMC9295026

[39] MpoulimariI.Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach.Psychiatr Genet2022;32:91-104

[40] DoiM,UsuiN.Genomic strategies for understanding the pathophysiology of autism spectrum disorder.Front Mol Neurosci2022;15:930941 PMCID:PMC9263364

[41] CasanovaMF,GillbergC.Editorial: comorbidity and autism spectrum disorder.Front Psychiatry2020;11:617395 PMCID:PMC7714785

[42] Autistica. Personal tragedies, public crisis. Available from: https://www.autistica.org.uk/downloads/files/Personal-tragedies-public-crisis-ONLINE.pdf [Last accessed on 27 Dec 2022]

[43] WillsJ. Health and service provision for people with autism spectrum disorders: a survey of parents in the United Kingdom. Available from: https://www.thinkingautism.org.uk/wp-content/uploads/Health__Service_Provision_for_People_with_ASD_March2016.pdf [Last accessed on 27 Dec 2022]

[44] LordC,HavdahlA.The Lancet Commission on the future of care and clinical research in autism.Lancet Comm2021;399:271-334

[45] QiuS,LiY.Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses.Transl Psychiatry2022;12:249 PMCID:PMC9200752

[46] PanisiC,AbruzzoPM.Autism spectrum disorder from the womb to adulthood: suggestions for a paradigm shift.J Pers Med 202111:70 PMCID:PMC7912683

[47] MDPI. Special issue “a personalized medicine approach to the diagnosis and management of autism spectrum disorder”. Available from: https://www.mdpi.com/journal/jpm/special_issues/Personalized_Medicine_Approach_ASD [Last accessed on 27 Dec 2022]

[48] MDPI. Special issue “a personalized medicine approach to the diagnosis and management of autism spectrum disorder: 2022”. Available from: https://www.mdpi.com/journal/jpm/special_issues/asd_personalized [Last accessed on 27 Dec 2022]

[49] WhiteleyP,KapoorRR,SalaR.Autoimmune encephalitis and autism spectrum disorder.Front Psychiatry2021;12:775017 PMCID:PMC8718789

[50] WhiteleyP,ShattockP.Research, clinical, and sociological aspects of autism.Front Psychiatry2021;12:481546 PMCID:PMC8116543

[51] ChenYJ,GeorgiadesS.Rethinking autism intervention science: a dynamic perspective.Front Psychiatry2022;13:827406 PMCID:PMC8915252

[52] ErbescuA,BudisteanuM,NeaguM.Re-emerging concepts of immune dysregulation in autism spectrum disorders.Front Psychiatry2022;13:1006612 PMCID:PMC9626859

[53] JensenAR,WernerBA,FletcherTS.Modern biomarkers for autism spectrum disorder: future directions.Mol Diagn Ther2022;26:483-95 PMCID:PMC9411091

[54] IakouchevaLM,SebatJ.Getting to the cores of autism.Cell2019;178:1287-98 PMCID:PMC7039308

[55] PaulsenB,KedaigleAJ.Autism genes converge on asynchronous development of shared neuron classes.Nature2022;602:268-73 PMCID:PMC8852827

[56] ShenL,LinJ.A combined proteomics and metabolomics profiling to investigate the genetic heterogeneity of autistic children.Mol Neurobiol2022;59:3529-45

[57] RoeK.Autism spectrum disorder initiation by inflammation-facilitated neurotoxin transport.Neurochem Res2022;47:1150-65

[58] OhashiK,MiyachiT.Comprehensive genetic analysis of non-syndromic autism spectrum disorder in clinical settings.J Autism Dev Disord2021;51:4655-62

[59] YuKH,FoxK.The phenotypical implications of immune dysregulation in fragile X syndrome.Eur J Neurol2020;27:590-3

[60] StartinCM,BallG.Health comorbidities and cognitive abilities across the lifespan in Down syndrome.J Neurodev Disord2020;12:4 PMCID:PMC6979347